D-0647-2024 Class II Ongoing
FDA drug recall D-0647-2024 was initiated by Preferred Pharmaceuticals, Inc. on Aug 8, 2024 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications - at 18-month Stability testing The recall status is ongoing. Affected quantity: 266 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Sep 4, 2024
- Initiation Date
- Aug 8, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 266 bottles
Product Description
Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.
Reason for Recall
Failed Impurities/Degradation Specifications - at 18-month Stability testing
Distribution Pattern
CA and NV
Code Information
Lot: B0223H, Exp: 5/31/2026; C3023H, Exp: 9/30/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0647-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026